BOXABL Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223042599 Filed on November 24, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q2

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$18.57M	$27.48M	$11.77M
Short-Term Investments
Other Short-Term Assets	$676.0K
YoY Change	34.66%
Inventory	$18.69M	$17.80M
Prepaid Expenses		$144.2K
Receivables	$26.00K	$59.44K
Other Receivables
Total Short-Term Assets	$65.66M	$75.98M
YoY Change	-28.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.77M	$11.09M
YoY Change	39.13%
Goodwill
YoY Change
Intangibles	$369.0K	$322.5K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$41.87M	$35.25M
YoY Change	133.56%
TOTAL ASSETS
Total Short-Term Assets	$65.66M	$75.98M
Total Long-Term Assets	$41.87M	$35.25M
Total Assets	$107.5M	$111.2M
YoY Change	-2.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.349M	$2.980M
YoY Change	83.27%
Accrued Expenses		$822.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.52M	$13.84M
YoY Change	58.28%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$10.66M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.52M	$13.84M
Total Long-Term Liabilities	$10.66M
Total Liabilities	$25.18M	$25.32M
YoY Change	105.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$667.5M	-$651.4M
YoY Change	6.57%
Common Stock	$30.00K
YoY Change	-90.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$82.35M	$85.91M	$91.00M
YoY Change
Total Liabilities & Shareholders Equity	$107.5M	$111.2M
YoY Change	-2.32%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	BOXABL	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001816937
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022Q4	BOXABL	Subscription Liability SubscriptionLiability		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	BOXABL	Service Revenues ServiceRevenues		usd
CY2022Q3	BOXABL	Service Revenues ServiceRevenues		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Other Income OtherIncome		usd
CY2022Q3	us-gaap	Other Income OtherIncome		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
CY2023Q3	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
CY2022Q3	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
	BOXABL	Forgiveness Of Debt ForgivenessOfDebt		usd
CY2023Q3	BOXABL	Forgiveness Of Debt ForgivenessOfDebt		usd
CY2022Q3	BOXABL	Forgiveness Of Debt ForgivenessOfDebt		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2023Q3	us-gaap	Interest Expense InterestExpense		usd
CY2022Q3	us-gaap	Interest Expense InterestExpense		usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	BOXABL	Deemed Dividends DeemedDividends		usd
CY2023Q3	BOXABL	Deemed Dividends DeemedDividends		usd
CY2022Q3	BOXABL	Deemed Dividends DeemedDividends		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	BOXABL	Payment For Deposits PaymentForDeposits		usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	BOXABL	Escrow Receivable EscrowReceivable		usd
	BOXABL	Escrow Receivable EscrowReceivable		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	BOXABL	Rightofuse Asset And Liability RightofuseAssetAndLiability		usd
	BOXABL	Acquistion Of Patents With Series A2 AcquistionOfPatentsWithSeriesA2		usd
	BOXABL	Non Cash Deemed Dividends NonCashDeemedDividends		usd
	BOXABL	Series A1 Preferred Stock Issued Conversion Of Convertible Notes And Accrued Interest SeriesA1PreferredStockIssuedConversionOfConvertibleNotesAndAccruedInterest		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56579
	dei	Entity Registrant Name EntityRegistrantName	Boxabl Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2511929
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5345 E. N. Belt Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	North Las Vegas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89115
	dei	City Area Code CityAreaCode	(702)
	dei	Local Phone Number LocalPhoneNumber	500-9000
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3000000000	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27483666	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9024802	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	29820605	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	74384612	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	59438	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	17795382	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8242947	usd
CY2023Q3	BOXABL	Deposits On Inventory DepositsOnInventory	672158	usd
CY2022Q4	BOXABL	Deposits On Inventory DepositsOnInventory	264067	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	144161	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	178584	usd
CY2023Q3	BOXABL	Deposits In Escrow DepositsInEscrow	3235	usd
CY2022Q4	BOXABL	Deposits In Escrow DepositsInEscrow	60838	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	75978645	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	92155850	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	1508022	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1461244	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11090398	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7738093	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	322493	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14296269	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3685561	usd
CY2023Q3	BOXABL	Deposits On Equipment DepositsOnEquipment	6891912	usd
CY2022Q4	BOXABL	Deposits On Equipment DepositsOnEquipment	3901537	usd
CY2023Q3	BOXABL	Deposits Noncurrent DepositsNoncurrent	1140116	usd
CY2022Q4	BOXABL	Deposits Noncurrent DepositsNoncurrent	1140116	usd
CY2023Q3	BOXABL	Property Plant And Equipment Other Assets PropertyPlantAndEquipmentOtherAssets	35249210	usd
CY2022Q4	BOXABL	Property Plant And Equipment Other Assets PropertyPlantAndEquipmentOtherAssets	17926551	usd
CY2023Q3	us-gaap	Assets Assets	111227855	usd
CY2022Q4	us-gaap	Assets Assets	110082401	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2980248	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1281734	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	822089	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1095753	usd
CY2023Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	4087324	usd
CY2022Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	4257424	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2572005	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1505491	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3108030	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1000225	usd
CY2023Q3	BOXABL	Subscription Liability SubscriptionLiability	245832	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	19750	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	31265	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13835278	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9171892	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11481374	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3090823	usd
CY2023Q3	us-gaap	Liabilities Liabilities	25316652	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12262715	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6600000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6600000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3002000000.000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3002000000.000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3000000000.000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3000000000.000	shares
CY2023Q3	BOXABL	Common Stock Payable Value CommonStockPayableValue	300000	usd
CY2022Q4	BOXABL	Common Stock Payable Value CommonStockPayableValue	300000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8911921	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3088921	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-651369338	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-626313828	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	85911203	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97819686	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	111227855	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	110082401	usd
	us-gaap	Revenues Revenues	160094	usd
	us-gaap	Revenues Revenues	7818746	usd
CY2023Q3	us-gaap	Revenues Revenues	62830	usd
CY2022Q3	us-gaap	Revenues Revenues	170000	usd
	BOXABL	Service Revenues ServiceRevenues	36500	usd
CY2023Q3	BOXABL	Service Revenues ServiceRevenues	36500	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7525107	usd
	us-gaap	Cost Of Revenue CostOfRevenue	18415106	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	3476331	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	5920404	usd
	us-gaap	Gross Profit GrossProfit	-7328513	usd
	us-gaap	Gross Profit GrossProfit	-10596360	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-3377001	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-5750404	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10180733	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7314244	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3133966	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2999553	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4779434	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4965438	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1667104	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1654245	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5104363	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2708984	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2138835	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1030735	usd
	us-gaap	Operating Expenses OperatingExpenses	20064530	usd
	us-gaap	Operating Expenses OperatingExpenses	14988666	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	6939905	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5684533	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27393043	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25585026	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10316906	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11434937	usd
	us-gaap	Interest Income Other InterestIncomeOther	2395651	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	749738	usd
	us-gaap	Other Income OtherIncome	49530	usd
CY2023Q3	us-gaap	Other Income OtherIncome	27992	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-107648	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	577325408	usd
	BOXABL	Forgiveness Of Debt ForgivenessOfDebt	-49166	usd
	us-gaap	Interest Expense InterestExpense	910635	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2337533	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-578186877	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	777730	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25055510	usd
	us-gaap	Net Income Loss NetIncomeLoss	-603771903	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-9539176	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11434937	usd
	BOXABL	Deemed Dividends DeemedDividends	-29724541	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-54780051	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-603771903	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9539176	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11434937	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3000000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3000000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3000000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3000000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3000000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3000000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3000000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3000000000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	67229609	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	63725	usd
CY2022Q3	BOXABL	Stock Issued During Period Value New Issues One StockIssuedDuringPeriodValueNewIssuesOne	238880	usd
CY2022Q3	BOXABL	Stock Issued During Period Value New Issues Two StockIssuedDuringPeriodValueNewIssuesTwo	43094304	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-2659614	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	813000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11434937	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	97344967	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	90995930	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1578403	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-76954	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2953000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-9539176	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	85911203	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6798453	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	74529	usd
	BOXABL	Stock Issued During Period Value New Issues One StockIssuedDuringPeriodValueNewIssuesOne	593360	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	623587058	usd
	BOXABL	Stock Issued During Period Value New Issues Two StockIssuedDuringPeriodValueNewIssuesTwo	88018076	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-5260700	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	903000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-603771903	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	97344967	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97819686	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97819686	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7583716	usd
	BOXABL	Stock Issued During Period Value New Issues On Common Control Transacation StockIssuedDuringPeriodValueNewIssuesOnCommonControlTransacation	30000000	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	29724541	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-535148	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5823000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25055510	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	85911203	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	85911203	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25055510	usd
	us-gaap	Net Income Loss NetIncomeLoss	-603771903	usd
	BOXABL	Forgiveness Of Paycheck Protection Program Loan ForgivenessOfPaycheckProtectionProgramLoan	49166	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1257160	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	809705	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5823000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	903000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	479449	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-577328258	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-107648	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	59438	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-419689	usd
	BOXABL	Increase Decrease In Deposit On Inventory IncreaseDecreaseInDepositOnInventory	408091	usd
	BOXABL	Increase Decrease In Deposit On Inventory IncreaseDecreaseInDepositOnInventory	-606636	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9552435	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2801673	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-34423	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	28758	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1698514	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-427573	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1066514	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4278332	usd
	BOXABL	Increase Decrease In Accrued Interest On Convertible Notes IncreaseDecreaseInAccruedInterestOnConvertibleNotes	314425	usd
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-112497	usd
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-1184099	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-273664	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-30176	usd
	BOXABL	Increase Decrease In Right Of Use Assets Or Liabilities IncreaseDecreaseInRightOfUseAssetsOrLiabilities	-11515	usd
	BOXABL	Increase Decrease In Right Of Use Assets Or Liabilities IncreaseDecreaseInRightOfUseAssetsOrLiabilities	-39533	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-112352	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-9291	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26077692	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32238791	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7757488	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4047810	usd
	BOXABL	Payment For Deposits PaymentForDeposits	611616	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	44996677	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	37239189	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4659426	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14405261	usd
	BOXABL	Payments Of Offering Costs PaymentsOfOfferingCosts	535148	usd
	BOXABL	Payments Of Offering Costs PaymentsOfOfferingCosts	5308690	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	7586683	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	88685965	usd
	BOXABL	Proceeds From Accrual Of Subscription Liability ProceedsFromAccrualOfSubscriptionLiability	245832	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7297367	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	97782536	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18458864	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	60884319	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9024802	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21415506	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27483666	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	82299825	usd
	BOXABL	Rightofuse Asset And Liability RightofuseAssetAndLiability	11019563	usd
	BOXABL	Acquistion Of Patents With Series A2 AcquistionOfPatentsWithSeriesA2	272493	usd
	BOXABL	Non Cash Deemed Dividends NonCashDeemedDividends	29724541	usd
	BOXABL	Series A1 Preferred Stock Issued Conversion Of Convertible Notes And Accrued Interest SeriesA1PreferredStockIssuedConversionOfConvertibleNotesAndAccruedInterest	46857860	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zakwb1i0Wef4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zVXVcSteryz9">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates form the basis for judgements the Company makes about the carrying value of its assets and liabilities, which are not readily apparent from other sources. These estimates are based on information available as of the date of the consolidated financial statements, including historical information and various other assumptions that the Company believes are reasonable under the circumstances. GAAP requires the Company to make estimates in several areas, including, but not limited to, those relevant to revenue recognition, valuation of stock-based compensation including warrants, warranty liabilities, and the estimated useful lives of property and equipment, reserves on inventory. These judgements, estimates and assumptions are inherently subjective in nature and actual results may differ from these estimates and assumptions, and the differences could be material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	4257424	usd
CY2023Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	4087324	usd
CY2022Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	4257424	usd
CY2022Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	4257424	usd
CY2021Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	1767424	usd
	BOXABL	Customer Additional Deposits Current CustomerAdditionalDepositsCurrent	435100	usd
	BOXABL	Customer Additional Deposits Current CustomerAdditionalDepositsCurrent	3337395	usd
	BOXABL	Customer Refunded Deposits Current CustomerRefundedDepositsCurrent	-605200	usd
	BOXABL	Customer Refunded Deposits Current CustomerRefundedDepositsCurrent	-847395	usd
CY2023Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	4087324	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P15Y
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_84C_eus-gaap--RevenueRecognitionDeferredRevenue_zPLxBhPJszii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zbkGG111MNQ8">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines revenue recognition through the following steps in accordance with ASC Topic 606, <i>Revenue from Contracts with Customers</i>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Identification of a contract with a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Identification of the performance obligations in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Determination of the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Allocation of the transaction price to the performance obligations in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Recognition of revenue when or as the performance obligations are satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues are recognized when performance obligations are satisfied through the transfer of promised goods to the Company’s customers. Control transfers upon shipment of product and when the title has been passed to the customers. This includes the transfer of legal title, physical possession, the risk and rewards of ownership, and customer acceptance. Revenue is recorded net of sales tax collected from customers on behalf of taxing authorities, allowance for estimated returns, chargebacks, and markdowns based upon management’s estimates and the Company’s historical experience. The Company records a liability for deposits for future products. The liability is relieved, and revenue is recognized once the revenue recognition criteria is met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to our method for recognizing revenue, deferred revenue reflects payment in advance received from our customers for Boxes, spare parts and services related active sales orders that had not yet been delivered and/or rendered as of the date of the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferred Revenue Activity</i></span></p> <p id="xdx_891_eus-gaap--DeferredRevenueByArrangementDisclosureTextBlock_zyyTut7QdfT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="display: none; background-color: white">SCHEDULE OF DEFERRED REVENUE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b>September 30,</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Deferred revenue – beginning period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredRevenue_iS_c20230101__20230930_zFJdNjRIvski" style="width: 16%; text-align: right" title="Deferred revenue - beginning period">1,505,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredRevenue_iS_c20220101__20221231_zGB6ckvAT9v3" style="width: 16%; text-align: right" title="Deferred revenue - beginning period">5,467,332</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Additions</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredRevenueAdditions_c20230101__20230930_zJfAlZkNOLH7" style="text-align: right" title="Additions">1,189,696</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredRevenueAdditions_c20220101__20221231_zv7LpYFt5y4i" style="text-align: right" title="Additions">4,499,491</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Revenue Recognized</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredRevenueRevenueRecognized1_iN_di_c20230101__20230930_z4Gd6EfuYxub" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue Recognized">(123,182</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DeferredRevenueRevenueRecognized1_iN_di_c20220101__20221231_zxFdLSZtX87c" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue Recognized">(8,461,332</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Deferred Revenue – end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredRevenue_iE_c20230101__20230930_zZqNKF5YbjGa" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue - end of period">2,572,005</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredRevenue_iE_c20220101__20221231_zjR1y2Dm33hi" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue - end of period">1,505,491</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zsn06USXWSrc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1257160	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1505491	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	5467332	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	1189696	usd
CY2022	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	4499491	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	123182	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	8461332	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	2572005	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1505491	usd
	us-gaap	Cost Direct Material CostDirectMaterial	59803	usd
CY2022	us-gaap	Cost Direct Material CostDirectMaterial	10575432	usd
	us-gaap	Cost Direct Labor CostDirectLabor	12107	usd
CY2022	us-gaap	Cost Direct Labor CostDirectLabor	3420744	usd
	us-gaap	Manufacturing Costs ManufacturingCosts	4483467	usd
CY2022	us-gaap	Manufacturing Costs ManufacturingCosts	3958400	usd
	BOXABL	Cost Stock Compensation CostStockCompensation	2969730	usd
CY2022	BOXABL	Cost Stock Compensation CostStockCompensation	460530	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7525107	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	18415106	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	809705	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1826237	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	4875922	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5104363	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2708984	usd
	BOXABL	Warrant On Products Term WarrantOnProductsTerm	P10Y
	BOXABL	Reserve On Warrant ReserveOnWarrant	570000	usd
CY2022	BOXABL	Reserve On Warrant ReserveOnWarrant	570000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-107648	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	1133795	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	2044430	usd
CY2022Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	910635	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	44800271	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	2044430	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zn0Cy0gy6kQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zY2UIobqcJ2c">Concentration of Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash and Cash Equivalents:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose the Company to a concentration of credit risk consist primarily of cash and cash equivalents. Cash and cash equivalents are maintained at high quality financial institutions. During the nine months ended September 30, 2023, and 2022, the Company exceeded the Federal Deposit Insurance Corporation (FDIC) limit. The Company has not experienced any losses with respect to its cash balances. Based upon assessment of the financial condition of these institutions, management believes that the risk of loss of any uninsured amounts is minimal.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inventory:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company imports a substantial part of its materials from overseas vendors, from China. Consequently, the Company’s ability to purchase and the costs of its products are subject to political, social, and economic situations, both in the United States and abroad. The Company maintains that the loss of one or more vendors would not have a material impact on the Company’s operations as replacements could be identified.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Customers</i>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from <span id="xdx_904_ecustom--NumberOfCustomer_pid_dc_uCustomer_c20220101__20220930_zxdxgeUtmIK" title="Number of customer">one</span> customer were approximately <span id="xdx_900_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_dp_uPure_c20220930_zEcxGK0LNQ5" title="Revenue, remaining performance obligation, percentage">95</span>% of the Company’s revenues for the nine months ended September 30, 2022. As the Company does not expect to have recurring customers prospectively, the loss of an individual customer is not expected to impact on the Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
	BOXABL	Number Of Customer NumberOfCustomer	1	customer
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.95	pure
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1324928714	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1235278447	shares
	us-gaap	Net Income Loss NetIncomeLoss	-25055510	usd
	us-gaap	Net Income Loss NetIncomeLoss	-603771903	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	29820605	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	74384612	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2395651	usd
	BOXABL	Investment Realized Interest InvestmentRealizedInterest	1916203	usd
	BOXABL	Investment Unrealized Interest InvestmentUnrealizedInterest	479448	usd
	us-gaap	Interest Expense InterestExpense	910635	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	577325408	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	577325408	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2904532	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	4550403	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	231934	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	182544	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14658916	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3510000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	17795382	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8242947	usd
CY2023Q3	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1760	usd
CY2023Q3	BOXABL	Inventory Labor InventoryLabor	1320	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13789241	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9233685	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2698843	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1495592	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11090398	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7738093	usd
CY2020Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P65M
CY2020Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	173000	sqft
CY2020Q4	us-gaap	Security Deposit SecurityDeposit	525000	usd
CY2020Q4	us-gaap	Payments For Rent PaymentsForRent	87229	usd
CY2020Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	19109	usd
CY2020Q4	BOXABL	Rents Increase Percentage RentsIncreasePercentage	0.03	pure
CY2023Q2	us-gaap	Payments For Rent PaymentsForRent	115759	usd
CY2023Q2	BOXABL	Rents Increase Percentage RentsIncreasePercentage	0.04	pure
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	3714190	usd
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P73M
CY2022Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	132960	sqft
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	611616	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	122323	usd
CY2022	BOXABL	Initial Base Rent InitialBaseRent	103709	usd
CY2022	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	18614	usd
CY2022Q4	BOXABL	Rents Increase Percentage RentsIncreasePercentage	0.04	pure
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	7409	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14296269	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3685561	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3108030	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1000225	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11481374	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3090823	usd
	us-gaap	Payments For Rent PaymentsForRent	2303969	usd
	us-gaap	Payments For Rent PaymentsForRent	930867	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	66683	usd
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	48150	usd
	us-gaap	Royalty Expense RoyaltyExpense	0	usd
	us-gaap	Royalty Expense RoyaltyExpense	76487	usd
	BOXABL	Percentage Of Gross Sales PercentageOfGrossSales	0.01	pure
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1211108527	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1211108527	shares
CY2023Q3	BOXABL	Preferred Stock Liquidation Preference Shares PreferredStockLiquidationPreferenceShares	205013346	shares
CY2023Q3	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	535148	usd
CY2022Q3	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	5260700	usd
CY2023Q3	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	245832	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0350	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4160	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.65
	BOXABL	Future Expected Share Based Compensation FutureExpectedShareBasedCompensation	13000000	usd

Files In Submission

Name	View Source	Status
0001493152-23-042599-index-headers.html	Edgar Link	pending
0001493152-23-042599-index.html	Edgar Link	pending
0001493152-23-042599.txt	Edgar Link	pending
0001493152-23-042599-xbrl.zip	Edgar Link	pending
boxabl-20230930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
boxabl-20230930_cal.xml	Edgar Link	unprocessable
boxabl-20230930_pre.xml	Edgar Link	unprocessable
boxabl-20230930_def.xml	Edgar Link	unprocessable
boxabl-20230930_lab.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

BOXABL Inc.

2023 Q4 Form 10-Q Financial Statement

#000149315223042599 Filed on November 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission